THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 110 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foundation Asset Management, LP | 933,881 | $13,934,000 | 3.34% |
| Baupost Group | 6,061,228 | $90,434,000 | 1.78% |
| Clearline Capital LP | 250,550 | $3,738,000 | 0.58% |
| Rock Springs Capital Management LP | 290,000 | $4,327,000 | 0.51% |
| Roundview Capital LLC | 41,917 | $625,000 | 0.26% |
| Old West Investment Management, LLC | 19,811 | $295,000 | 0.18% |
| HighVista Strategies LLC | 86,700 | $1,294,000 | 0.17% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 296,234 | $4,420,000 | 0.17% |
| FIRST MANHATTAN CO. LLC. | 1,446,960 | $21,588,000 | 0.12% |
| REINHART PARTNERS, LLC. | 71,850 | $1,072,000 | 0.08% |